Home › Companies › Indivior Pharmaceuticals, Inc. › 2025-2026

Indivior Pharmaceuticals, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Indivior Pharmaceuticals, Inc.’s Form 8-K, filed 2026-05-15 (Item 5.07 on EDGAR). Page generated 04 October 2026.

27Reported items
313Asset managers
5,246Fund votes
2026-05-13Main meeting date

Proxy season: 2025-2026

Explore Indivior Pharmaceuticals, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Indivior Pharmaceuticals, Inc.

These tallies are Indivior Pharmaceuticals, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-15 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Indivior Pharmaceuticals, Inc. — official shareholder meeting results, meeting held 2026-05-13
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Dr. David Wheadon	91,378,828	1,534,064	24,804	--	7,470,026	Majority: yes
Elect Director: Joe Ciaffoni	92,834,811	76,839	26,046	--	7,470,026	Majority: yes
Elect Director: Dr. Keith Humphreys	92,839,955	72,084	25,657	--	7,470,026	Majority: yes
Elect Director: Tony Kingsley	92,839,469	72,503	25,724	--	7,470,026	Majority: yes
Elect Director: Daniel Ninivaggi	87,545,032	5,366,849	25,815	--	7,470,026	Majority: yes
Elect Director: Barbara Ryan	91,562,195	1,302,383	73,118	--	7,470,026	Majority: yes
Elect Director: Mark Stejbach	92,838,962	72,847	25,887	--	7,470,026	Majority: yes
Elect Director: Juliet Thompson	92,136,342	728,040	73,314	--	7,470,026	Majority: yes
Proposal 2: To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement (Say-on-Pay):	90,364,566	1,324,996	1,248,134	--	7,470,026	Majority: yes
Proposal 3: To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers (Say-on-Frequency):	91,848,954	--	34,100	--	7,470,026	—
Proposal 4: To ratify the appointment of PricewaterhouseCoopers LLP US (PwC) as our independent registered public accounting firm for the fiscal year ending December 31, 2026:	99,146,241	1,237,984	23,497	--	0	Majority: yes

Source: Indivior Pharmaceuticals, Inc., Form 8-K, filed with the SEC on 2026-05-15 — read the filing on EDGAR.

How asset managers voted at the Indivior Pharmaceuticals, Inc. 2025-2026 meetings

Each item below shows how the 313 asset managers that disclosed a Indivior Pharmaceuticals, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Indivior Pharmaceuticals, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 90,364,566AGAINST: 1,324,996

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Proposal 2: To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement (Say-on-Pay):”): 90,364,566 for, 1,324,996 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 74% for, 1% against (75% of the company cast a for/against vote).

The 292 asset managers below cast 99.4% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 99.4%

FOR: 99.4%AGAINST: 0.5%ABSTAIN: 0.0%

Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	17,203,465	0	For
OAKTREE CAPITAL MANAGEMENT LP	6,977,658	0	For
Vanguard	6,226,120	7	For
Two Seas Capital LP	5,640,461	0	For
FULLER & THALER ASSET MANAGEMENT, INC.	5,553,691	0	For
Capitol Series Trust	4,481,759	0	For
State Street	4,466,705	3,925	For
Fidelity	3,557,968	0	For
DEERFIELD MANAGEMENT COMPANY, L.P.	3,097,790	0	For
Madison Avenue Partners, LP	2,993,510	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,894,831	0	For
Charles Schwab	2,315,955	0	For
Newtyn Management, LLC	2,194,205	0	For
Citadel	2,178,574	0	For
Federated Hermes	1,959,578	8,792	For
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	1,900,712	0	For
Goldman Sachs	1,234,015	0	For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	1,177,024	0	For
Northern Trust	1,126,645	0	For
GENDELL JEFFREY L	1,096,343	0	For
DRIEHAUS CAPITAL MANAGEMENT LLC	1,094,968	0	For
ACADIAN ASSET MANAGEMENT LLC	1,038,584	0	For
Nuveen	945,516	0	For
TIAA	925,372	0	For
PRINCIPAL GLOBAL INVESTORS	772,518	0	For

Showing the 25 largest of 292 asset managers. See all 292 in the interactive database.

2. To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2026-05-13.

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 49.9%1 YEAR 43%

The 290 asset managers below cast 100% of the shares they voted on this item FOR (257,265 for, 0 against).

FOR: 257,265 (0.3%)ABSTAIN: 26,529 (0.0%)ONE YEAR: 49,593,992 (49.9%)1 YEAR: 43,172,742 (43.5%)1: 5,640,461 (5.7%)THREE YEARS: 549,935 (0.6%)3 YEARS: 53,845 (0.1%)1.0: 30,262 (0.0%)1-YEAR: 791 (0.0%)3.0: 6 (0.0%)

Largest asset managers voting on “To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation o” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
BlackRock	0	0	0	0	1 Year
OAKTREE CAPITAL MANAGEMENT LP	0	0	0	0	1 Year
Vanguard	0	0	0	0	One Year
Two Seas Capital LP	0	0	0	0	1
FULLER & THALER ASSET MANAGEMENT, INC.	0	0	0	0	One Year
Capitol Series Trust	0	0	0	0	One Year
State Street	0	0	0	0	One Year
Fidelity	0	0	0	0	One Year
DEERFIELD MANAGEMENT COMPANY, L.P.	0	0	0	0	1 Year
Madison Avenue Partners, LP	0	0	0	0	1 Year
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	One Year
Charles Schwab	0	0	0	0	1 Year
Newtyn Management, LLC	0	0	0	0	One Year
Citadel	0	0	0	0	One Year
Federated Hermes	0	0	0	0	1 Year
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	0	0	0	0	One Year
Goldman Sachs	0	0	0	0	1 Year
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	0	0	0	0	One Year
Northern Trust	0	0	0	0	1 Year
GENDELL JEFFREY L	0	0	0	0	1 Year
DRIEHAUS CAPITAL MANAGEMENT LLC	0	0	0	0	One Year
ACADIAN ASSET MANAGEMENT LLC	0	0	0	0	One Year
Nuveen	0	0	0	0	One Year
TIAA	0	0	0	0	One Year
PRINCIPAL GLOBAL INVESTORS	0	0	0	0	One Year

Showing the 25 largest of 290 asset managers. See all 290 in the interactive database.

3. Election of Directors: Barbara Ryan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 91,562,195AGAINST: 1,302,383

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Barbara Ryan”): 91,562,195 for, 1,302,383 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 75% for, 1% against (76% of the company cast a for/against vote).

The 87 asset managers below cast 99.9% of the shares they voted on this item FOR (35,533,537 for, 9,851 against).

FOR 99.9%

FOR: 35,533,537 (99.9%)AGAINST: 9,851 (0.0%)ABSTAIN: 19,753 (0.1%)

Largest asset managers voting on “Election of Directors: Barbara Ryan” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	12,789,498	0	For
Vanguard	5,290,242	3	For
Capitol Series Trust	4,481,759	0	For
Fidelity	3,033,045	0	For
State Street	2,054,025	0	For
Charles Schwab	1,124,471	0	For
TIAA	925,372	0	For
Federated Hermes	804,464	0	For
DRIEHAUS MUTUAL FUNDS	335,267	0	For
Bridge Builder Trust	290,560	0	For
Dimensional	287,435	0	For
American Century	272,586	0	For
Equitable	260,148	0	For
Jackson National	257,833	0	For
QUANTITATIVE MASTER SERIES LLC	199,483	0	For
Columbia Threadneedle	194,146	0	For
Lincoln Financial	165,347	0	For
Prudential/PGIM	165,257	0	For
Principal Exchange-Traded Funds	156,627	0	For
OLD WESTBURY FUNDS INC	113,400	0	For
BNY Mellon	111,228	0	For
Principal	109,026	0	For
SEI	108,632	0	For
MFS	103,908	0	For
Empower	90,742	0	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

4. Election of Directors: Daniel Ninivaggi

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 87,545,032AGAINST: 5,366,849

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Daniel Ninivaggi”): 87,545,032 for, 5,366,849 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 72% for, 4% against (76% of the company cast a for/against vote).

The 87 asset managers below cast 99.3% of the shares they voted on this item FOR (35,322,702 for, 220,687 against).

FOR 99.3%

FOR: 35,322,702 (99.3%)AGAINST: 220,687 (0.6%)ABSTAIN: 19,753 (0.1%)

Largest asset managers voting on “Election of Directors: Daniel Ninivaggi” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	12,789,498	0	For
Vanguard	5,273,553	16,693	For
Capitol Series Trust	4,481,759	0	For
Fidelity	3,033,045	0	For
State Street	2,054,025	0	For
Charles Schwab	1,124,471	0	For
TIAA	925,372	0	For
Federated Hermes	804,464	0	For
DRIEHAUS MUTUAL FUNDS	335,267	0	For
Bridge Builder Trust	290,560	0	For
Dimensional	287,435	0	For
American Century	272,586	0	For
Equitable	260,148	0	For
Jackson National	257,833	0	For
QUANTITATIVE MASTER SERIES LLC	199,483	0	For
Columbia Threadneedle	0	194,146	Against
Lincoln Financial	165,347	0	For
Prudential/PGIM	165,257	0	For
Principal Exchange-Traded Funds	156,627	0	For
OLD WESTBURY FUNDS INC	113,400	0	For
BNY Mellon	111,228	0	For
Principal	109,026	0	For
SEI	108,632	0	For
MFS	103,908	0	For
Empower	90,742	0	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

5. Election of Directors: Dr. David Wheadon

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 91,378,828AGAINST: 1,534,064

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Dr. David Wheadon”): 91,378,828 for, 1,534,064 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 75% for, 1% against (76% of the company cast a for/against vote).

The 87 asset managers below cast 99.9% of the shares they voted on this item FOR (35,516,869 for, 26,520 against).

FOR 99.8%

FOR: 35,516,869 (99.9%)AGAINST: 26,520 (0.1%)ABSTAIN: 19,753 (0.1%)

Largest asset managers voting on “Election of Directors: Dr. David Wheadon” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	12,789,498	0	For
Vanguard	5,273,574	16,672	For
Capitol Series Trust	4,481,759	0	For
Fidelity	3,033,045	0	For
State Street	2,054,025	0	For
Charles Schwab	1,124,471	0	For
TIAA	925,372	0	For
Federated Hermes	804,464	0	For
DRIEHAUS MUTUAL FUNDS	335,267	0	For
Bridge Builder Trust	290,560	0	For
Dimensional	287,435	0	For
American Century	272,586	0	For
Equitable	260,148	0	For
Jackson National	257,833	0	For
QUANTITATIVE MASTER SERIES LLC	199,483	0	For
Columbia Threadneedle	194,146	0	For
Lincoln Financial	165,347	0	For
Prudential/PGIM	165,257	0	For
Principal Exchange-Traded Funds	156,627	0	For
OLD WESTBURY FUNDS INC	113,400	0	For
BNY Mellon	111,228	0	For
Principal	109,026	0	For
SEI	108,632	0	For
MFS	103,908	0	For
Empower	90,742	0	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

6. Election of Directors: Dr. Keith Humphreys

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 4 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 92,839,955AGAINST: 72,084

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Dr. Keith Humphreys”): 92,839,955 for, 72,084 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 76% for, 0.1% against (76% of the company cast a for/against vote).

The 87 asset managers below cast 100% of the shares they voted on this item FOR (35,543,389 for, 0 against).

FOR 99.9%

FOR: 35,543,389 (99.9%)ABSTAIN: 19,753 (0.1%)

Largest asset managers voting on “Election of Directors: Dr. Keith Humphreys” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
BlackRock	12,789,498	For
Vanguard	5,290,246	For
Capitol Series Trust	4,481,759	For
Fidelity	3,033,045	For
State Street	2,054,025	For
Charles Schwab	1,124,471	For
TIAA	925,372	For
Federated Hermes	804,464	For
DRIEHAUS MUTUAL FUNDS	335,267	For
Bridge Builder Trust	290,560	For
Dimensional	287,435	For
American Century	272,586	For
Equitable	260,148	For
Jackson National	257,833	For
QUANTITATIVE MASTER SERIES LLC	199,483	For
Columbia Threadneedle	194,146	For
Lincoln Financial	165,347	For
Prudential/PGIM	165,257	For
Principal Exchange-Traded Funds	156,627	For
OLD WESTBURY FUNDS INC	113,400	For
BNY Mellon	111,228	For
Principal	109,026	For
SEI	108,632	For
MFS	103,908	For
Empower	90,742	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

7. Election of Directors: Joe Ciaffoni

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 92,834,811AGAINST: 76,839

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Joe Ciaffoni”): 92,834,811 for, 76,839 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 76% for, 0.1% against (76% of the company cast a for/against vote).

The 87 asset managers below cast 100% of the shares they voted on this item FOR (35,543,389 for, 0 against).

FOR 99.9%

FOR: 35,543,389 (99.9%)ABSTAIN: 19,753 (0.1%)

Largest asset managers voting on “Election of Directors: Joe Ciaffoni” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
BlackRock	12,789,498	For
Vanguard	5,290,246	For
Capitol Series Trust	4,481,759	For
Fidelity	3,033,045	For
State Street	2,054,025	For
Charles Schwab	1,124,471	For
TIAA	925,372	For
Federated Hermes	804,464	For
DRIEHAUS MUTUAL FUNDS	335,267	For
Bridge Builder Trust	290,560	For
Dimensional	287,435	For
American Century	272,586	For
Equitable	260,148	For
Jackson National	257,833	For
QUANTITATIVE MASTER SERIES LLC	199,483	For
Columbia Threadneedle	194,146	For
Lincoln Financial	165,347	For
Prudential/PGIM	165,257	For
Principal Exchange-Traded Funds	156,627	For
OLD WESTBURY FUNDS INC	113,400	For
BNY Mellon	111,228	For
Principal	109,026	For
SEI	108,632	For
MFS	103,908	For
Empower	90,742	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

8. Election of Directors: Juliet Thompson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%

FOR: 92,136,342AGAINST: 728,040

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Juliet Thompson”): 92,136,342 for, 728,040 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 76% for, 0.6% against (76% of the company cast a for/against vote).

The 87 asset managers below cast 99.9% of the shares they voted on this item FOR (35,533,539 for, 9,850 against).

FOR 99.9%

FOR: 35,533,539 (99.9%)AGAINST: 9,850 (0.0%)ABSTAIN: 19,753 (0.1%)

Largest asset managers voting on “Election of Directors: Juliet Thompson” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	12,789,498	0	For
Vanguard	5,290,244	2	For
Capitol Series Trust	4,481,759	0	For
Fidelity	3,033,045	0	For
State Street	2,054,025	0	For
Charles Schwab	1,124,471	0	For
TIAA	925,372	0	For
Federated Hermes	804,464	0	For
DRIEHAUS MUTUAL FUNDS	335,267	0	For
Bridge Builder Trust	290,560	0	For
Dimensional	287,435	0	For
American Century	272,586	0	For
Equitable	260,148	0	For
Jackson National	257,833	0	For
QUANTITATIVE MASTER SERIES LLC	199,483	0	For
Columbia Threadneedle	194,146	0	For
Lincoln Financial	165,347	0	For
Prudential/PGIM	165,257	0	For
Principal Exchange-Traded Funds	156,627	0	For
OLD WESTBURY FUNDS INC	113,400	0	For
BNY Mellon	111,228	0	For
Principal	109,026	0	For
SEI	108,632	0	For
MFS	103,908	0	For
Empower	90,742	0	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

9. Election of Directors: Mark Stejbach

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 92,838,962AGAINST: 72,847

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Mark Stejbach”): 92,838,962 for, 72,847 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 76% for, 0.1% against (76% of the company cast a for/against vote).

The 87 asset managers below cast 100% of the shares they voted on this item FOR (35,543,389 for, 0 against).

FOR 99.9%

FOR: 35,543,389 (99.9%)ABSTAIN: 19,753 (0.1%)

Largest asset managers voting on “Election of Directors: Mark Stejbach” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
BlackRock	12,789,498	For
Vanguard	5,290,246	For
Capitol Series Trust	4,481,759	For
Fidelity	3,033,045	For
State Street	2,054,025	For
Charles Schwab	1,124,471	For
TIAA	925,372	For
Federated Hermes	804,464	For
DRIEHAUS MUTUAL FUNDS	335,267	For
Bridge Builder Trust	290,560	For
Dimensional	287,435	For
American Century	272,586	For
Equitable	260,148	For
Jackson National	257,833	For
QUANTITATIVE MASTER SERIES LLC	199,483	For
Columbia Threadneedle	194,146	For
Lincoln Financial	165,347	For
Prudential/PGIM	165,257	For
Principal Exchange-Traded Funds	156,627	For
OLD WESTBURY FUNDS INC	113,400	For
BNY Mellon	111,228	For
Principal	109,026	For
SEI	108,632	For
MFS	103,908	For
Empower	90,742	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

10. Election of Directors: Tony Kingsley

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 92,839,469AGAINST: 72,503

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Tony Kingsley”): 92,839,469 for, 72,503 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 76% for, 0.1% against (76% of the company cast a for/against vote).

The 87 asset managers below cast 100% of the shares they voted on this item FOR (35,543,389 for, 0 against).

FOR 99.9%

FOR: 35,543,389 (99.9%)ABSTAIN: 19,753 (0.1%)

Largest asset managers voting on “Election of Directors: Tony Kingsley” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
BlackRock	12,789,498	For
Vanguard	5,290,246	For
Capitol Series Trust	4,481,759	For
Fidelity	3,033,045	For
State Street	2,054,025	For
Charles Schwab	1,124,471	For
TIAA	925,372	For
Federated Hermes	804,464	For
DRIEHAUS MUTUAL FUNDS	335,267	For
Bridge Builder Trust	290,560	For
Dimensional	287,435	For
American Century	272,586	For
Equitable	260,148	For
Jackson National	257,833	For
QUANTITATIVE MASTER SERIES LLC	199,483	For
Columbia Threadneedle	194,146	For
Lincoln Financial	165,347	For
Prudential/PGIM	165,257	For
Principal Exchange-Traded Funds	156,627	For
OLD WESTBURY FUNDS INC	113,400	For
BNY Mellon	111,228	For
Principal	109,026	For
SEI	108,632	For
MFS	103,908	For
Empower	90,742	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

11. To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2026-05-13.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 99,146,241AGAINST: 1,237,984

Indivior Pharmaceuticals, Inc.’s own tally for this item (“Proposal 4: To ratify the appointment of PricewaterhouseCoopers LLP US (PwC) as our independent registered public accounting firm for the fiscal year ending December 31, 2026:”): 99,146,241 for, 1,237,984 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 121,922,058 outstanding shares: 81% for, 1% against (82% of the company cast a for/against vote).

The 87 asset managers below cast 99.8% of the shares they voted on this item FOR (35,491,835 for, 51,554 against).

FOR 99.7%

FOR: 35,491,835 (99.8%)AGAINST: 51,554 (0.1%)ABSTAIN: 19,753 (0.1%)

Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting f” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	12,789,498	0	For
Vanguard	5,290,239	7	For
Capitol Series Trust	4,481,759	0	For
Fidelity	3,033,045	0	For
State Street	2,054,025	0	For
Charles Schwab	1,124,471	0	For
TIAA	925,372	0	For
Federated Hermes	804,464	0	For
DRIEHAUS MUTUAL FUNDS	335,267	0	For
Bridge Builder Trust	290,560	0	For
Dimensional	287,435	0	For
American Century	272,586	0	For
Equitable	260,148	0	For
Jackson National	257,833	0	For
QUANTITATIVE MASTER SERIES LLC	199,483	0	For
Columbia Threadneedle	194,146	0	For
Lincoln Financial	165,347	0	For
Prudential/PGIM	165,257	0	For
Principal Exchange-Traded Funds	156,627	0	For
OLD WESTBURY FUNDS INC	113,400	0	For
BNY Mellon	111,228	0	For
Principal	109,026	0	For
SEI	108,632	0	For
MFS	103,908	0	For
Empower	90,742	0	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

12. Adopt New Articles of Association

CORPORATE GOVERNANCE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 53 asset managers below cast 100% of the shares they voted on this item FOR (15,701,308 for, 0 against).

FOR: 15,701,308 (100.0%)

Largest asset managers voting on “Adopt New Articles of Association” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
Capitol Series Trust	5,066,959	For
Vanguard	3,148,971	For
Fidelity	2,631,827	For
TIAA	928,722	For
Victory Capital	531,253	For
OBERWEIS FUNDS	424,941	For
DRIEHAUS MUTUAL FUNDS	344,512	For
American Century	314,694	For
Royce	305,710	For
Equitable	268,336	For
Dimensional	239,309	For
Lincoln Financial	180,322	For
Thrivent	140,234	For
Principal Exchange-Traded Funds	92,867	For
Northern Trust	80,266	For
Voya	74,026	For
RBB FUND, INC.	66,751	For
OLD WESTBURY FUNDS INC	66,629	For
AIG/SunAmerica	59,711	For
Prudential/PGIM	59,450	For
State Street	44,703	For
Nationwide	44,495	For
Brighthouse	43,428	For
MFS	43,122	For
JPMorgan	42,506	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

13. Amend Articles of Association

CORPORATE GOVERNANCE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 53 asset managers below cast 100% of the shares they voted on this item FOR (15,701,308 for, 0 against).

FOR: 15,701,308 (100.0%)

Largest asset managers voting on “Amend Articles of Association” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
Capitol Series Trust	5,066,959	For
Vanguard	3,148,971	For
Fidelity	2,631,827	For
TIAA	928,722	For
Victory Capital	531,253	For
OBERWEIS FUNDS	424,941	For
DRIEHAUS MUTUAL FUNDS	344,512	For
American Century	314,694	For
Royce	305,710	For
Equitable	268,336	For
Dimensional	239,309	For
Lincoln Financial	180,322	For
Thrivent	140,234	For
Principal Exchange-Traded Funds	92,867	For
Northern Trust	80,266	For
Voya	74,026	For
RBB FUND, INC.	66,751	For
OLD WESTBURY FUNDS INC	66,629	For
AIG/SunAmerica	59,711	For
Prudential/PGIM	59,450	For
State Street	44,703	For
Nationwide	44,495	For
Brighthouse	43,428	For
MFS	43,122	For
JPMorgan	42,506	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

14. Approve Re-registration of the Company as a Private Company by the Name of Indivior Limited

EXTRAORDINARY TRANSACTIONS

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 53 asset managers below cast 100% of the shares they voted on this item FOR (15,701,308 for, 0 against).

FOR: 15,701,308 (100.0%)

Largest asset managers voting on “Approve Re-registration of the Company as a Private Company by the Name of Indivior Limited” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
Capitol Series Trust	5,066,959	For
Vanguard	3,148,971	For
Fidelity	2,631,827	For
TIAA	928,722	For
Victory Capital	531,253	For
OBERWEIS FUNDS	424,941	For
DRIEHAUS MUTUAL FUNDS	344,512	For
American Century	314,694	For
Royce	305,710	For
Equitable	268,336	For
Dimensional	239,309	For
Lincoln Financial	180,322	For
Thrivent	140,234	For
Principal Exchange-Traded Funds	92,867	For
Northern Trust	80,266	For
Voya	74,026	For
RBB FUND, INC.	66,751	For
OLD WESTBURY FUNDS INC	66,629	For
AIG/SunAmerica	59,711	For
Prudential/PGIM	59,450	For
State Street	44,703	For
Nationwide	44,495	For
Brighthouse	43,428	For
MFS	43,122	For
JPMorgan	42,506	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

15. Approve Reduction in Share Capital

CAPITAL STRUCTURE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 53 asset managers below cast 100% of the shares they voted on this item FOR (15,701,308 for, 0 against).

FOR: 15,701,308 (100.0%)

Largest asset managers voting on “Approve Reduction in Share Capital” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
Capitol Series Trust	5,066,959	For
Vanguard	3,148,971	For
Fidelity	2,631,827	For
TIAA	928,722	For
Victory Capital	531,253	For
OBERWEIS FUNDS	424,941	For
DRIEHAUS MUTUAL FUNDS	344,512	For
American Century	314,694	For
Royce	305,710	For
Equitable	268,336	For
Dimensional	239,309	For
Lincoln Financial	180,322	For
Thrivent	140,234	For
Principal Exchange-Traded Funds	92,867	For
Northern Trust	80,266	For
Voya	74,026	For
RBB FUND, INC.	66,751	For
OLD WESTBURY FUNDS INC	66,629	For
AIG/SunAmerica	59,711	For
Prudential/PGIM	59,450	For
State Street	44,703	For
Nationwide	44,495	For
Brighthouse	43,428	For
MFS	43,122	For
JPMorgan	42,506	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

16. Approve Scheme of Arrangement

EXTRAORDINARY TRANSACTIONS

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 53 asset managers below cast 100% of the shares they voted on this item FOR (15,701,308 for, 0 against).

FOR: 15,701,308 (100.0%)

Largest asset managers voting on “Approve Scheme of Arrangement” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
Capitol Series Trust	5,066,959	For
Vanguard	3,148,971	For
Fidelity	2,631,827	For
TIAA	928,722	For
Victory Capital	531,253	For
OBERWEIS FUNDS	424,941	For
DRIEHAUS MUTUAL FUNDS	344,512	For
American Century	314,694	For
Royce	305,710	For
Equitable	268,336	For
Dimensional	239,309	For
Lincoln Financial	180,322	For
Thrivent	140,234	For
Principal Exchange-Traded Funds	92,867	For
Northern Trust	80,266	For
Voya	74,026	For
RBB FUND, INC.	66,751	For
OLD WESTBURY FUNDS INC	66,629	For
AIG/SunAmerica	59,711	For
Prudential/PGIM	59,450	For
State Street	44,703	For
Nationwide	44,495	For
Brighthouse	43,428	For
MFS	43,122	For
JPMorgan	42,506	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

17. Authorize Issue of Equity

CAPITAL STRUCTURE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 53 asset managers below cast 100% of the shares they voted on this item FOR (15,701,308 for, 0 against).

FOR: 15,701,308 (100.0%)

Largest asset managers voting on “Authorize Issue of Equity” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
Capitol Series Trust	5,066,959	For
Vanguard	3,148,971	For
Fidelity	2,631,827	For
TIAA	928,722	For
Victory Capital	531,253	For
OBERWEIS FUNDS	424,941	For
DRIEHAUS MUTUAL FUNDS	344,512	For
American Century	314,694	For
Royce	305,710	For
Equitable	268,336	For
Dimensional	239,309	For
Lincoln Financial	180,322	For
Thrivent	140,234	For
Principal Exchange-Traded Funds	92,867	For
Northern Trust	80,266	For
Voya	74,026	For
RBB FUND, INC.	66,751	For
OLD WESTBURY FUNDS INC	66,629	For
AIG/SunAmerica	59,711	For
Prudential/PGIM	59,450	For
State Street	44,703	For
Nationwide	44,495	For
Brighthouse	43,428	For
MFS	43,122	For
JPMorgan	42,506	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

18. To approve the Scheme as set forth in the Scheme Circular.

CORPORATE GOVERNANCE

Meeting held 2025-12-11; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 32 asset managers below cast 99.9% of the shares they voted on this item FOR (7,774,547 for, 7,245 against).

FOR: 7,774,547 (99.9%)AGAINST: 7,245 (0.1%)

Largest asset managers voting on “To approve the Scheme as set forth in the Scheme Circular.” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	4,431,609	0	For
Charles Schwab	1,151,423	0	For
Alta Fundamental Advisers LLC	464,049	0	For
Federated Hermes	398,758	0	For
Pacer Funds Trust	345,940	0	For
SEI	238,087	0	For
QUANTITATIVE MASTER SERIES LLC	202,492	0	For
Calamos	112,856	0	For
TARGET PORTFOLIO TRUST	77,700	0	For
Global X	58,289	0	For
TRUST FOR PROFESSIONAL MANAGERS	57,869	0	For
Jackson National	51,321	0	For
John Hancock	37,704	0	For
Bridge Builder Trust	28,130	0	For
MASTER INVESTMENT PORTFOLIO	27,917	0	For
Prudential/PGIM	22,298	0	For
New York Life	16,806	0	For
Russell Investments	10,907	0	For
Venerable Variable Insurance Trust	9,914	0	For
TIFF INVESTMENT PROGRAM	8,732	0	For
NYLIM VP FUNDS TRUST	8,065	0	For
Brighthouse	0	7,245	Against
GoldenTree Opportunistic Credit Fund	3,318	0	For
Nationwide	2,962	0	For
Simplify Exchange Traded Funds	2,671	0	For

Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.

19. To authorise (a) the paying up, allotment and issue of New Indivior Shares and (b) to authorise the Directors to allot such New Indivior Shares

CAPITAL STRUCTURE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 99.9%

The 31 asset managers below cast 100% of the shares they voted on this item FOR (7,311,680 for, 0 against).

FOR: 7,311,680 (99.9%)ABSTAIN: 7,245 (0.1%)

Largest asset managers voting on “To authorise (a) the paying up, allotment and issue of New Indivior Shares and (b) to authorise the Directors ” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	4,431,609	0	For
Charles Schwab	1,151,423	0	For
Federated Hermes	398,758	0	For
Pacer Funds Trust	345,940	0	For
SEI	238,087	0	For
QUANTITATIVE MASTER SERIES LLC	202,492	0	For
Calamos	112,856	0	For
TARGET PORTFOLIO TRUST	77,700	0	For
Global X	58,289	0	For
TRUST FOR PROFESSIONAL MANAGERS	57,869	0	For
Jackson National	51,321	0	For
John Hancock	37,704	0	For
Bridge Builder Trust	28,130	0	For
MASTER INVESTMENT PORTFOLIO	27,917	0	For
Prudential/PGIM	22,298	0	For
New York Life	16,806	0	For
Russell Investments	10,907	0	For
Venerable Variable Insurance Trust	9,914	0	For
TIFF INVESTMENT PROGRAM	8,732	0	For
NYLIM VP FUNDS TRUST	8,065	0	For
Brighthouse	0	7,245	Abstain
GoldenTree Opportunistic Credit Fund	3,318	0	For
Nationwide	2,962	0	For
Simplify Exchange Traded Funds	2,671	0	For
WILSHIRE MUTUAL FUNDS INC	2,002	0	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

20. To authorise amendments to the existing articles of association of Indivior

CORPORATE GOVERNANCE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 99.9%

The 31 asset managers below cast 100% of the shares they voted on this item FOR (7,311,680 for, 0 against).

FOR: 7,311,680 (99.9%)ABSTAIN: 7,245 (0.1%)

Largest asset managers voting on “To authorise amendments to the existing articles of association of Indivior” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	4,431,609	0	For
Charles Schwab	1,151,423	0	For
Federated Hermes	398,758	0	For
Pacer Funds Trust	345,940	0	For
SEI	238,087	0	For
QUANTITATIVE MASTER SERIES LLC	202,492	0	For
Calamos	112,856	0	For
TARGET PORTFOLIO TRUST	77,700	0	For
Global X	58,289	0	For
TRUST FOR PROFESSIONAL MANAGERS	57,869	0	For
Jackson National	51,321	0	For
John Hancock	37,704	0	For
Bridge Builder Trust	28,130	0	For
MASTER INVESTMENT PORTFOLIO	27,917	0	For
Prudential/PGIM	22,298	0	For
New York Life	16,806	0	For
Russell Investments	10,907	0	For
Venerable Variable Insurance Trust	9,914	0	For
TIFF INVESTMENT PROGRAM	8,732	0	For
NYLIM VP FUNDS TRUST	8,065	0	For
Brighthouse	0	7,245	Abstain
GoldenTree Opportunistic Credit Fund	3,318	0	For
Nationwide	2,962	0	For
Simplify Exchange Traded Funds	2,671	0	For
WILSHIRE MUTUAL FUNDS INC	2,002	0	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

21. To authorise the Directors to take all necessary action to give effect to the Scheme

CAPITAL STRUCTURE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 99.9%

The 31 asset managers below cast 100% of the shares they voted on this item FOR (7,311,680 for, 0 against).

FOR: 7,311,680 (99.9%)ABSTAIN: 7,245 (0.1%)

Largest asset managers voting on “To authorise the Directors to take all necessary action to give effect to the Scheme” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	4,431,609	0	For
Charles Schwab	1,151,423	0	For
Federated Hermes	398,758	0	For
Pacer Funds Trust	345,940	0	For
SEI	238,087	0	For
QUANTITATIVE MASTER SERIES LLC	202,492	0	For
Calamos	112,856	0	For
TARGET PORTFOLIO TRUST	77,700	0	For
Global X	58,289	0	For
TRUST FOR PROFESSIONAL MANAGERS	57,869	0	For
Jackson National	51,321	0	For
John Hancock	37,704	0	For
Bridge Builder Trust	28,130	0	For
MASTER INVESTMENT PORTFOLIO	27,917	0	For
Prudential/PGIM	22,298	0	For
New York Life	16,806	0	For
Russell Investments	10,907	0	For
Venerable Variable Insurance Trust	9,914	0	For
TIFF INVESTMENT PROGRAM	8,732	0	For
NYLIM VP FUNDS TRUST	8,065	0	For
Brighthouse	0	7,245	Abstain
GoldenTree Opportunistic Credit Fund	3,318	0	For
Nationwide	2,962	0	For
Simplify Exchange Traded Funds	2,671	0	For
WILSHIRE MUTUAL FUNDS INC	2,002	0	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

22. To authorise the adoption of the Post-Scheme Articles of Association

CAPITAL STRUCTURE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 99.9%

The 31 asset managers below cast 100% of the shares they voted on this item FOR (7,311,680 for, 0 against).

FOR: 7,311,680 (99.9%)ABSTAIN: 7,245 (0.1%)

Largest asset managers voting on “To authorise the adoption of the Post-Scheme Articles of Association” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	4,431,609	0	For
Charles Schwab	1,151,423	0	For
Federated Hermes	398,758	0	For
Pacer Funds Trust	345,940	0	For
SEI	238,087	0	For
QUANTITATIVE MASTER SERIES LLC	202,492	0	For
Calamos	112,856	0	For
TARGET PORTFOLIO TRUST	77,700	0	For
Global X	58,289	0	For
TRUST FOR PROFESSIONAL MANAGERS	57,869	0	For
Jackson National	51,321	0	For
John Hancock	37,704	0	For
Bridge Builder Trust	28,130	0	For
MASTER INVESTMENT PORTFOLIO	27,917	0	For
Prudential/PGIM	22,298	0	For
New York Life	16,806	0	For
Russell Investments	10,907	0	For
Venerable Variable Insurance Trust	9,914	0	For
TIFF INVESTMENT PROGRAM	8,732	0	For
NYLIM VP FUNDS TRUST	8,065	0	For
Brighthouse	0	7,245	Abstain
GoldenTree Opportunistic Credit Fund	3,318	0	For
Nationwide	2,962	0	For
Simplify Exchange Traded Funds	2,671	0	For
WILSHIRE MUTUAL FUNDS INC	2,002	0	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

23. To authorise the re-registration of Indivior as a private company limited by shares

CORPORATE GOVERNANCE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 31 asset managers below cast 100% of the shares they voted on this item FOR (7,318,925 for, 0 against).

FOR: 7,318,925 (100.0%)

Largest asset managers voting on “To authorise the re-registration of Indivior as a private company limited by shares” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
BlackRock	4,431,609	For
Charles Schwab	1,151,423	For
Federated Hermes	398,758	For
Pacer Funds Trust	345,940	For
SEI	238,087	For
QUANTITATIVE MASTER SERIES LLC	202,492	For
Calamos	112,856	For
TARGET PORTFOLIO TRUST	77,700	For
Global X	58,289	For
TRUST FOR PROFESSIONAL MANAGERS	57,869	For
Jackson National	51,321	For
John Hancock	37,704	For
Bridge Builder Trust	28,130	For
MASTER INVESTMENT PORTFOLIO	27,917	For
Prudential/PGIM	22,298	For
New York Life	16,806	For
Russell Investments	10,907	For
Venerable Variable Insurance Trust	9,914	For
TIFF INVESTMENT PROGRAM	8,732	For
NYLIM VP FUNDS TRUST	8,065	For
Brighthouse	7,245	For
GoldenTree Opportunistic Credit Fund	3,318	For
Nationwide	2,962	For
Simplify Exchange Traded Funds	2,671	For
WILSHIRE MUTUAL FUNDS INC	2,002	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

24. To authorise the reduction of share capital

CAPITAL STRUCTURE

Meeting held 2025-12-11; no official results are on file for this meeting.

100% fund support · no official result

FOR 99.9%

The 31 asset managers below cast 100% of the shares they voted on this item FOR (7,311,680 for, 0 against).

FOR: 7,311,680 (99.9%)ABSTAIN: 7,245 (0.1%)

Largest asset managers voting on “To authorise the reduction of share capital” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	4,431,609	0	For
Charles Schwab	1,151,423	0	For
Federated Hermes	398,758	0	For
Pacer Funds Trust	345,940	0	For
SEI	238,087	0	For
QUANTITATIVE MASTER SERIES LLC	202,492	0	For
Calamos	112,856	0	For
TARGET PORTFOLIO TRUST	77,700	0	For
Global X	58,289	0	For
TRUST FOR PROFESSIONAL MANAGERS	57,869	0	For
Jackson National	51,321	0	For
John Hancock	37,704	0	For
Bridge Builder Trust	28,130	0	For
MASTER INVESTMENT PORTFOLIO	27,917	0	For
Prudential/PGIM	22,298	0	For
New York Life	16,806	0	For
Russell Investments	10,907	0	For
Venerable Variable Insurance Trust	9,914	0	For
TIFF INVESTMENT PROGRAM	8,732	0	For
NYLIM VP FUNDS TRUST	8,065	0	For
Brighthouse	0	7,245	Abstain
GoldenTree Opportunistic Credit Fund	3,318	0	For
Nationwide	2,962	0	For
Simplify Exchange Traded Funds	2,671	0	For
WILSHIRE MUTUAL FUNDS INC	2,002	0	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

25. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2026-05-13.

100% fund support · no official result

FOR 86%12%

The 10 asset managers below cast 100% of the shares they voted on this item FOR (1,329,821 for, 0 against).

FOR: 1,329,821 (86.3%)ONE YEAR: 183,296 (11.9%)NOT VOTED: 27,964 (1.8%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Vote
MANGROVE PARTNERS IM, LLC	1,246,692	For
Empower	0	One Year
Panoramic Capital, LLC	0	One Year
CLEARWATER INVESTMENT TRUST	52,849	For
GLOBEFLEX CAPITAL L P	30,280	For
JPMorgan	0	Not Voted
TD Waterhouse Canada Inc.	0	One Year
HBK INVESTMENTS L P	0	One Year
Sarasin & Partners LLP	0	One Year
CIDEL ASSET MANAGEMENT INC	0	One Year

26. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2026-05-13.

99.9% fund support · no official result

FOR 98%

The 10 asset managers below cast 99.9% of the shares they voted on this item FOR (1,512,785 for, 332 against).

FOR: 1,512,785 (98.2%)AGAINST: 332 (0.0%)NOT VOTED: 27,964 (1.8%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Vote
MANGROVE PARTNERS IM, LLC	1,246,692	0	For
Empower	90,742	0	For
Panoramic Capital, LLC	89,011	0	For
CLEARWATER INVESTMENT TRUST	52,849	0	For
GLOBEFLEX CAPITAL L P	30,280	0	For
JPMorgan	0	0	Not Voted
TD Waterhouse Canada Inc.	2,596	0	For
HBK INVESTMENTS L P	614	0	For
Sarasin & Partners LLP	0	332	Against
CIDEL ASSET MANAGEMENT INC	1	0	For

27. To approve, on an advisory basis, the compensation of our named executive officers

SECTION 14A SAY-ON-PAY VOTES

Reported under meeting date 2026-03-18; no official results on file for that date.

Combines 2 wordings of this item as funds reported it.

57% fund support · no official result

FOR 57%AGAINST 43%

The 2 asset managers below cast 57% of the shares they voted on this item FOR (100,000 for, 74,850 against).

FOR: 100,000 (57.2%)AGAINST: 74,850 (42.8%)

Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers” at Indivior Pharmaceuticals, Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
Stonepine Capital Management, LLC	100,000	0	0	0	For
SCHRODER INVESTMENT MANAGEMENT GROUP	0	74,850	0	0	Against

Largest Indivior Pharmaceuticals, Inc. shareholders voting in 2025-2026

Ranked by the number of Indivior Pharmaceuticals, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 121,922,058 shares outstanding at the time of that meeting.

Top Indivior Pharmaceuticals, Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	BlackRock	14.11%
2	OAKTREE CAPITAL MANAGEMENT LP	5.72%
3	Vanguard	5.11%
4	Two Seas Capital LP	4.63%
5	FULLER & THALER ASSET MANAGEMENT, INC.	4.56%
6	Capitol Series Trust	3.68%
7	State Street	3.67%
8	Fidelity	2.92%
9	DEERFIELD MANAGEMENT COMPANY, L.P.	2.54%
10	Madison Avenue Partners, LP	2.46%

Reported Indivior Pharmaceuticals, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Indivior Pharmaceuticals, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	15.21%	13F
Vanguard Portfolio Management	6.56%	13G
Oaktree Capital Group Holdings LP	5.83%	DEF14A
Vanguard Capital Management	5.35%	13G
Madison Avenue Partners LP	5.15%	DEF14A
State Street	4.02%	13F
Millennium Management	3.77%	13F
Fuller & Thaler Asset Management, Inc.	3.72%	13G
Madison Avenue International LP	3.54%	13G
Citadel Advisors	3.04%	13F

Percentages above are of 121,922,058 shares outstanding, as reported by Indivior Pharmaceuticals, Inc. on its Form 10-Q dated 2026-04-01 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Indivior Pharmaceuticals, Inc.’s 10-Q dated 2026-04-01. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Indivior Pharmaceuticals, Inc.'s 2 shareholder meetings in the 2025-2026 proxy season (held 2025-12-11 and 2026-05-13), 313 asset managers reported how they voted in their SEC Form N-PX filings, covering 5,246 separate fund positions. Their filings are grouped here into 27 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2026-05-13 — To approve, on an advisory basis, the compensation of our named executive officers. — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Indivior Pharmaceuticals, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-15.

Indivior Pharmaceuticals, Inc. proxy season coverage: 2025-2026 (this page).